Table 2.
Comorbidities of 525 symptomatic COVID-19 patients.
| Comorbidities | No | Yes | ||
|---|---|---|---|---|
| n | % | n | % | |
| Presence of any comorbidities | 241 | 45.90 | 284 | 54 |
| Diabetes mellitus | 348 | 66 | 177 | 34 |
| Hypertension | 359 | 68 | 166 | 32 |
| Cardiovascular disease | 498 | 95 | 27 | 5 |
| Thyroid dysfunction | 509 | 97 | 16 | 3 |
| Chronic lung disease | 511 | 97 | 14 | 3 |
| Chronic kidney disease | 512 | 98 | 13 | 2 |
| Stroke | 521 | 99.24 | 4 | 0.76 |
| Cancer | 522 | 99.43 | 3 | 0.57 |
| Epilepsy | 524 | 99.8 | 1 | 0.2 |
| Multiple sclerosis | 524 | 99.8 | 1 | 0.2 |
| Autoimmune rheumatic diseases | 523 | 99.6 | 2 | 0.4 |
| Thalassemia | 524 | 99.8 | 1 | 0.2 |
Data presented as n; number and %; percentage.